Rituximab for refractory granulomatous eye disease
Elyse E Lower1,2 Robert P Baughman,1 Adam H Kaufman31Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA; 2Oncology Hematology Care, Cincinnati, OH, USA; 3Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USAObjective: To determine the effectiven...
Guardado en:
Autores principales: | Lower EE, Baughman RP, Kaufman AH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4403196810ac4e698ac7c5da40ffb2cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
por: Sáles CS, et al.
Publicado: (2014) -
Update on thyroid eye disease and management
por: Erick D Bothun, et al.
Publicado: (2009) -
Diagnosis of dry eye disease and emerging technologies
por: Zeev MSB, et al.
Publicado: (2014) -
Etiology, prevalence, and treatment of dry eye disease
por: Johnny L Gayton
Publicado: (2009) -
Surgical treatment for medically refractory myasthenic blepharoptosis
por: Shimizu Y, et al.
Publicado: (2014)